Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Arkansas
With
National Heart, Lung, and Blood Institute (NHLBI)
This is a study on volunteers to determine effective dose of dexrazoxane in degrading Topoisomerase 2 b in human blood samples. Each participant will receive one dose of dexrazoxane. Blood samples will be collected to determine the time course and degradation of Topoisomerase 2b and Topoisomerase 2a
Age
18–65
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
Women,
Age 18-65,
Not pregnant, Not currently breast feeding
No current illness,
You may not be if
Pregnancy, currently breast feeding
Current illness,
History of cardiac, or renal disease
Clareo Health | Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane
